Documents likely contradict Warren?s claim of not knowing Harvard promoted her as minority

[ [ [['Connery is an experienced stuntman', 2]], 'http://yhoo.it/KeQd0p', '[Slideshow: See photos taken on the way down]', ' ', '630', ' ', ' ', ], [ [['Connery is an experienced stuntman', 7]], ' http://yhoo.it/KpUoHO', '[Slideshow: Death-defying daredevils]', ' ', '630', ' ', ' ', ], [ [['know that we have confidence in', 3]], 'http://yhoo.it/LqYjAX ', '[Related: The Secret Service guide to Cartagena]', ' ', '630', ' ', ' ', ], [ [['We picked up this other dog and', 5]], 'http://yhoo.it/JUSxvi', '[Related: 8 common dog fears, how to calm them]', ' ', '630', ' ', ' ', ], [ [['accused of running a fake hepatitis B', 5]], 'http://bit.ly/JnoJYN', '[Related: Did WH share raid details with filmmakers?]', ' ', '630', ' ', ' ', ], [ [['accused of running a fake hepatitis B', 3]], 'http://bit.ly/KoKiqJ', '[Factbox: AQAP, al-Qaeda in Yemen]', ' ', '630', ' ', ' ', ], [ [['have my contacts on or glasses', 3]], 'http://abcn.ws/KTE5AZ', '[Related: Should the murder charge be dropped?]', ' ', '630', ' ', ' ', ], [ [['have made this nation great as Sarah Palin', 5]], 'http://yhoo.it/JD7nlD', '[Related: Bristol Palin reality show debuts June 19]', ' ', '630', ' ', ' ', ], [ [['have made this nation great as Sarah Palin', 1]], 'http://bit.ly/JRPFRO', '[Related: McCain adviser who vetted Palin weighs in on VP race]', ' ', '630', ' ', ' ', ], [ [['A JetBlue flight from New York to Las Vegas', 3]], 'http://yhoo.it/GV9zpj', '[Related: View photos of the JetBlue plane in Amarillo]', ' ', '630', ' ', ' ', ], [ [['the 28-year-old neighborhood watchman who shot and killed', 15]], 'http://news.yahoo.com/photos/white-house-stays-out-of-teen-s-killing-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/cv/ip/ap/default/120411/martinzimmermen.jpg', '630', ' ', 'AP', ], [ [['Titanic', 7]], 'http://news.yahoo.com/titanic-anniversary/', ' ', 'http://l.yimg.com/a/p/us/news/editorial/b/4e/b4e5ad9f00b5dfeeec2226d53e173569.jpeg', '550', ' ', ' ', ], [ [['He was in shock and still strapped to his seat', 6]], 'http://news.yahoo.com/photos/navy-jet-crashes-in-virginia-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/cv/ip/ap/default/120406/jet_ap.jpg', '630', ' ', 'AP', ], [ [['xxxxxxxxxxxx', 11]], 'http://news.yahoo.com/photos/russian-grannies-win-bid-to-sing-at-eurovision-1331223625-slideshow/', 'Click image to see more photos', 'http://l.yimg.com/a/p/us/news/editorial/1/56/156d92f2760dcd3e75bcd649a8b85fcf.jpeg', '500', ' ', 'AP', ] ]

[ [ [['did not go as far his colleague', 8]], '29438204', '0' ], [ [[' the 28-year-old neighborhood watchman who shot and killed', 4]], '28924649', '0' ], [ [['because I know God protects me', 14], ['Brian Snow was at a nearby credit union', 5]], '28811216', '0' ], [ [['The state news agency RIA-Novosti quoted Rosaviatsiya', 6]], '28805461', '0' ], [ [['measure all but certain to fail in the face of bipartisan', 4]], '28771014', '0' ], [ [['matter what you do in this case', 5]], '28759848', '0' ], [ [['presume laws are constitutional', 7]], '28747556', '0' ], [ [['has destroyed 15 to 25 houses', 7]], '28744868', '0' ], [ [['short answer is yes', 7]], '28746030', '0' ], [ [['opportunity to tell the real story', 7]], '28731764', '0' ], [ [['entirely respectable way to put off the searing constitutional controversy', 7]], '28723797', '0' ], [ [['point of my campaign is that big ideas matter', 9]], '28712293', '0' ], [ [['As the standoff dragged into a second day', 7]], '28687424', '0' ], [ [['French police stepped up the search', 17]], '28667224', '0' ], [ [['Seeking to elevate his candidacy back to a general', 8]], '28660934', '0' ], [ [['The tragic story of Trayvon Martin', 4]], '28647343', '0' ], [ [['Karzai will get a chance soon to express', 8]], '28630306', '0' ], [ [['powerful storms stretching', 8]], '28493546', '0' ], [ [['basic norm that death is private', 6]], '28413590', '0' ], [ [['songwriter also saw a surge in sales for her debut album', 6]], '28413590', '1', 'Watch music videos from Whitney Houston ', 'on Yahoo! Music', 'http://music.yahoo.com' ], [ [['keyword', 99999999999999999999999]], 'videoID', '1', 'overwrite-pre-description', 'overwrite-link-string', 'overwrite-link-url' ] ]

food network good friday

Forum Financial Launches New Equipment Leasing ... - Monitordaily

Forum Financial Services (Forum Leasing) said it is launching a new leasing division focusing on companies in the North Texas area. DFW Equipment Leasing will target most credit types on equipment with an acquisition cost of $10,000 to $1 million.

As part of offering a comprehensive lease program, this new division will have an online ?Application Only? up to $100,000 on most types of equipment. DFW Equipment Leasing will provide for a variety of lease structures including $1.00 buyouts and fair market value lease options. This new offering will be spearheaded by Tim O?Connor and Bryon Tansel and will be available to a select group of lease brokers.

Established in 1996, Forum Leasing is a national equipment leasing company specializing in middle-market distressed credits and venture capital backed corporations.

For more information on DFW Equipment Leasing click here.

Other Recent Headlines...

phantom of the opera agoraphobia andrew lloyd webber obscura grok cirque du freak

Weight Loss Systems | The Best Diet To Lose Weight

Simple System To Lose Weight Than Jenny Craig! ? YouTube
Fellow Health Seekers are constantly on the search for the following: Weight Loss Systems, Anti Aging, Personal Fitness Training, Longevity, Medicines, Health and Fitness Clubs, Yoga Instructors, Healthy Systems, Baby Boomer Diets, Low Carb Diets, Calorie Counting, Healthy Lifestyle ? View Video

Kim Kardashian: Does She Endorse Any Products That Aren’t Dubious?
*Celebrity endorsements rarely make much sense. Despite what Hulk Hogan and Troy Aikman have said, for instance, it’s foolish to pay double the retail price for a TV from Rent-A-Center. Even so, the endorsement-crazed “famous for being famous” Kim Kardashian is a special case. Based on her history of endorsing goods that are of dubious [] ? Read News

Here are some weight loss related sites that I have found for you to browse!

The Fat Trap - NYTimes.com
Diet Doc HCG Diet & Weight Loss Announces Diet ... - Yahoo! News
Diabetes - diabetes obesity weight loss health medicine - latimes ...
Reducing diet encyclopedia topics | Reference.com

ncaa march madness mario williams vcu unlv sam young

Welcome To My Naperville Home-Based Business Blog | Naperville ...

Hello. Welcome to the Naperville home based business blog. This site contains articles about home based businesses and other self-employment opportunities. We cover a broad range of topics including:

• The best Naperville home based businesses
• Advice for first time business owners
• How to use technology to advertise your home based business
• Expanding your network in Naperville, Illinois
• SEO tips for your online business
• Managing your online store
• Quality customer service

Hundreds of Glendale Heights entrepreneurs have home businesses of all sizes. They range from one man or woman shops to large organizations with dozens of employees or independent contractors.

If you are a home based business owner in Naperville, we invite you to visit us often. If you would like to learn about the Glendale Heights Xocai Xe Energy Drink opportunity, contact me today. You can email me at 384adampaulgreen@adampaulgreen.com or call me at 801.437.5984 to set up a meeting.

Join Winner?s Circle today!

I am Adam Paul Green, and I am a Naperville-based Xocai artisan chocolate distributor. I joined Xocai in December 2010. I sell the industry-leading Xe Energy Drink and Xocai Xe Energy Drink online and in Naperville, Batavia, Lombard, and Lisle. Our valued Glendale Heights customers recommend Xocai Xe Energy Drink because Xocai Xe Energy Drink chocolates can be good for you!.

Winner?s Circle is also a fantastic Xe Energy Drink home-based business within 66 miles of the Glendale Heights area. Illinois entrepreneurs can supplement their income by cashing in on a high-demand Illinois healthy artisan chocolate market. To learn more about Winner?s Circle, visit http://adampaulgreen.com/partnership/.

Call me at 801.437.5984 to own your own Xe Energy Drink business in Naperville, Batavia, Lombard, or Lisle.

The URL for my personal Glendale Heights Xocai chocolate web page in Naperville, Illinois 60563 is http://adampaulgreen.com/partnership/. The URL for another one of my 66 Illinois Xocai artisan chocolate web pages is http://adampaulgreen.com/resources/jeanette-brooks/. I also have a Illinois healthy chocolate page at http://adampaulgreen.com/contact/.

This entry was posted in Home Business. Bookmark the permalink.

dexter dexter facebook timeline kim jong il kim jong il vaclav havel vaclav havel

Government employees have limited privacy rights ? Business ...

Public employees don?t lose all privacy rights just because they work for the government. But that privacy is subject to limitations.

Recent case: Teacher Ari Marken was accused of sexually harassing a student. The student?s mother complained and an investigation followed.

The investigator concluded that Marken violated district sexual har??assment rules, based on his own statements, finding that some of the allegations ?more likely than not did occur.? Marken was reprimanded.

Another parent later sued, seeking disclosure of the investigation file. Marken sought to keep it confidential. His request was denied based on the public?s right to know, which outweighed his privacy rights. (Marken v. Santa Monica-Malibu Unified School District, Court of Appeal of California, 2nd Appellate District, 2012)

Like what you've read? ...Republish it and share great business tips!

Attention: Readers, Publishers, Editors, Bloggers, Media, Webmasters and more...

We believe great content should be read and passed around. After all, knowledge IS power. And good business can become great with the right information at their fingertips. If you'd like to share any of the insightful articles on BusinessManagementDaily.com, you may republish or syndicate it without charge.

The only thing we ask is that you keep the article exactly as it was written and formatted. You also need to include an attribution statement and link to the article.

" This information is proudly provided by Business Management Daily.com: http://www.businessmanagementdaily.com/30667/government-employees-have-limited-privacy-rights "

annie oakley edc paranormal activity 4 love and hip hop 2012 nfl mock draft iowa caucus lemonade diet

UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure

Public release date: 18-May-2012
[ | E-mail | Share ]

Contact: Mike Ferrari
mike.ferrari@uhhospitals.org
216-844-7239
University Hospitals Case Medical Center

Results presented at EuroPCR demonstrate minimally invasive Parachute device could transform treatment options for patients

CLEVELAND University Hospitals (UH) Case Medical Center and CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced promising results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration Therapy (PVRT) technology for patients with ischemic heart failure.

The two-year clinical results were presented today (May 18, 2012, 9 a.m.) during a Trials, Registries and Late Breaking Science Hot Line session at the 2012 EuroPCR Conference in Paris by UH Case Medical Center's Marco Costa, MD, Director of the Interventional Cardiovascular Center and the Research and Innovation Center at UH Case Medical Center's Harrington Heart & Vascular Institute and Professor, Case Western Reserve University School of Medicine.

Clinical data from the two first-in-human studies of the Parachute system presented today show meaningful and sustained low clinical events two years following treatment with the device.

"Heart failure is such a morbid condition, and in spite of our best efforts, we have so little to offer to our patients," said Dr. Costa, who was the national principal investigator for the initial trial. "Today we shared unprecedented news for cardiologists and heart failure patients. This novel technology could revolutionize care for our patients because the procedure is relatively simple and the outcomes are surprisingly remarkable for such a high-risk population."

Results from 31 treated U.S and European patients demonstrate a near-full New York Heart Association (NYHA) class improvement at two years compared to baseline (2.6 vs. 1.9, p-value

"We are extremely pleased with the two-year clinical results from the Parachute implant. This data supports the design of our randomized pivotal trial, in which we anticipate a potential reduction of death and hospitalization due to worsening heart failure on the order of 30 to 50 percent for patients treated with the Parachute system compared to optimal medical therapy," said William T. Abraham, MD, director of the Division of Cardiovascular Medicine and professor of internal medicine, physiology and cell biology at The Ohio State University Medical Center who was also part of the first U.S. trial. "This innovative device has the potential to bring together two cardiology disciplines heart failure and interventional cardiology to address a significant unmet need in heart failure."

"The presentation of this long-term clinical data is an exciting milestone for CardioKinetix," said Maria Sainz, president and CEO of CardioKinetix. "We look forward to gathering additional evidence in our European trials of the clinical benefits of the Parachute and as we prepare to start our pivotal trial with the device, which we believe holds the potential to improve the lives of tens of thousands of patients around the world."

After a heart attack, many patients experience enlargement of the left ventricle of the heart, causing a decrease in cardiac output that results in heart failure symptoms such as fatigue and shortness of breath. The healthy portion of the heart not affected by the heart attack has to compensate for the loss in output and becomes overloaded overtime. Current treatment options for patients whose heart has enlarged are limited.

Through a small catheter inserted in the femoral artery (large thigh artery), the Parachute implant is deployed in the left ventricle to partition the damaged muscle, excluding the non-functional heart segment from the healthy, functional segment to decrease the overall volume of the left ventricle and restore its geometry and function. This minimally invasive procedure is performed in the catheterization laboratory under conscious sedation.

The next phase of the trial will be to enroll close to 500 patients in both the United States and Europe. UH Case Medical Center and The Ohio State University Medical Center will serve as the focal points for the efforts conducted nationally.

"The sustained and concordant improvements in symptoms, heart function and clinical outcomes are compelling, with a very acceptable safety profile," Dr. Costa said. "If these results are confirmed in the upcoming large randomized trial, the Parachute implant will transform the treatment of patients with ischemic dilated cardiomyopathy, reducing debilitating symptoms and dramatically improving the quality of life for our patients."

###

Heart failure is one of the most resource-intensive conditions with direct and indirect costs in the United States estimated at $39.2 billion in 2010. Symptoms of heart failure negatively impact quality of life and include shortness of breath, persistent coughing or wheezing, buildup of excess fluid in body tissues (edema), fatigue, lack of appetite or nausea, impaired thinking, and increased heart rate. An estimated 20 to 30 percent of heart failure patients could benefit from percutaneous ventricular restoration therapy with the Parachute. More than 20 million people around the world are affected, with approximately 6 million in the United States, where it is responsible for 1.1 million hospitalizations annually.

The Parachute Ventricular Partitioning Device received CE Mark in 2011. In the U.S., the Parachute system is an investigational device limited by federal law to investigational use only and is not available for sale.

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Public release date: 18-May-2012
[ | E-mail | Share ]

Contact: Mike Ferrari
mike.ferrari@uhhospitals.org
216-844-7239
University Hospitals Case Medical Center

Results presented at EuroPCR demonstrate minimally invasive Parachute device could transform treatment options for patients

CLEVELAND University Hospitals (UH) Case Medical Center and CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced promising results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration Therapy (PVRT) technology for patients with ischemic heart failure.

The two-year clinical results were presented today (May 18, 2012, 9 a.m.) during a Trials, Registries and Late Breaking Science Hot Line session at the 2012 EuroPCR Conference in Paris by UH Case Medical Center's Marco Costa, MD, Director of the Interventional Cardiovascular Center and the Research and Innovation Center at UH Case Medical Center's Harrington Heart & Vascular Institute and Professor, Case Western Reserve University School of Medicine.

Clinical data from the two first-in-human studies of the Parachute system presented today show meaningful and sustained low clinical events two years following treatment with the device.

"Heart failure is such a morbid condition, and in spite of our best efforts, we have so little to offer to our patients," said Dr. Costa, who was the national principal investigator for the initial trial. "Today we shared unprecedented news for cardiologists and heart failure patients. This novel technology could revolutionize care for our patients because the procedure is relatively simple and the outcomes are surprisingly remarkable for such a high-risk population."

Results from 31 treated U.S and European patients demonstrate a near-full New York Heart Association (NYHA) class improvement at two years compared to baseline (2.6 vs. 1.9, p-value

"We are extremely pleased with the two-year clinical results from the Parachute implant. This data supports the design of our randomized pivotal trial, in which we anticipate a potential reduction of death and hospitalization due to worsening heart failure on the order of 30 to 50 percent for patients treated with the Parachute system compared to optimal medical therapy," said William T. Abraham, MD, director of the Division of Cardiovascular Medicine and professor of internal medicine, physiology and cell biology at The Ohio State University Medical Center who was also part of the first U.S. trial. "This innovative device has the potential to bring together two cardiology disciplines heart failure and interventional cardiology to address a significant unmet need in heart failure."

"The presentation of this long-term clinical data is an exciting milestone for CardioKinetix," said Maria Sainz, president and CEO of CardioKinetix. "We look forward to gathering additional evidence in our European trials of the clinical benefits of the Parachute and as we prepare to start our pivotal trial with the device, which we believe holds the potential to improve the lives of tens of thousands of patients around the world."

After a heart attack, many patients experience enlargement of the left ventricle of the heart, causing a decrease in cardiac output that results in heart failure symptoms such as fatigue and shortness of breath. The healthy portion of the heart not affected by the heart attack has to compensate for the loss in output and becomes overloaded overtime. Current treatment options for patients whose heart has enlarged are limited.

Through a small catheter inserted in the femoral artery (large thigh artery), the Parachute implant is deployed in the left ventricle to partition the damaged muscle, excluding the non-functional heart segment from the healthy, functional segment to decrease the overall volume of the left ventricle and restore its geometry and function. This minimally invasive procedure is performed in the catheterization laboratory under conscious sedation.

The next phase of the trial will be to enroll close to 500 patients in both the United States and Europe. UH Case Medical Center and The Ohio State University Medical Center will serve as the focal points for the efforts conducted nationally.

"The sustained and concordant improvements in symptoms, heart function and clinical outcomes are compelling, with a very acceptable safety profile," Dr. Costa said. "If these results are confirmed in the upcoming large randomized trial, the Parachute implant will transform the treatment of patients with ischemic dilated cardiomyopathy, reducing debilitating symptoms and dramatically improving the quality of life for our patients."

###

Heart failure is one of the most resource-intensive conditions with direct and indirect costs in the United States estimated at $39.2 billion in 2010. Symptoms of heart failure negatively impact quality of life and include shortness of breath, persistent coughing or wheezing, buildup of excess fluid in body tissues (edema), fatigue, lack of appetite or nausea, impaired thinking, and increased heart rate. An estimated 20 to 30 percent of heart failure patients could benefit from percutaneous ventricular restoration therapy with the Parachute. More than 20 million people around the world are affected, with approximately 6 million in the United States, where it is responsible for 1.1 million hospitalizations annually.

The Parachute Ventricular Partitioning Device received CE Mark in 2011. In the U.S., the Parachute system is an investigational device limited by federal law to investigational use only and is not available for sale.

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

earthquake san francisco donald payne elizabeth berkley mlb 12 the show sabu

LG LS970 superphone rumored: Krait quad-core, 2GB RAM, LTE and 13MP camera

Not to be outdone by its Korean rival, LG's reportedly preparing a potent new phone with some of Qualcomm's latest SoC hardware. According to BriefMobile's leak, it'll pack an LTE-friendly MDM9615 alongside the Adreno 320 GPU and 2GB of RAM -- something LG has already announced for its Optimus LTE2. A 2,1000 mAh battery will apparently power the 4.67-inch 1280 x 768 LCD display, while a Sony-matching 13-megapixel camera will face out the back. The leak -- which includes the decidedly abstract photo above -- reckons the LTE slab will arrive on Sprint, which tallies with the LS970 model number. We're cautiously holding out for something more official soon -- perhaps once the Now Network's flipped that 4G switch.

LG LS970 superphone rumored: Krait quad-core, 2GB RAM, LTE and 13MP camera originally appeared on Engadget on Fri, 11 May 2012 07:28:00 EDT. Please see our terms for use of feeds.

Permalink   |  BriefMobile  | Email this | Comments

birth control pill recall ground hog day florida primary results black history groundhogs day paula abdul mitt romney